Early Dynamics of Chronic Myeloid Leukemia on Nilotinib Predicts Deep Molecular Response
Yuji Okamoto, Mitsuhito Hirano, Kai Morino, Masashi Kajita, Shinji Nakaoka, Mayuko Tsuda, Keiji Sugimoto, Shigehisa Tamaki, Junichi Hisatake, Hisayuki Yokoyama, Tadahiko Igarashi, Atsushi Shinagawa, Takeaki Sugawara, Satoru Hara, Kazuhisa Fujikawa, , Kazuyuki Aihara
This paper develops a mathematical model using early clinical data to predict deep molecular response in CML patients treated with nilotinib.
npj Systems Biology and Applications · Oct 13, 2022Peer-reviewedSystems Biology